durvalumab with olapirib shows no pfs improvement for platinum-ineligible bladder cancer
Published 2 years ago • 19 plays • Length 5:25Download video MP4
Download video MP3
Similar videos
-
3:32
dora: using olaparib alone or with durvalumab in platinum responsive advanced triple-negative br...
-
11:30
durvalumab following radiotherapy in patients with unresectable, stage 3 nsclc ineligible for ch...
-
2:02
intravesical io using durvalumab shows promising results for patients with high-risk nmibc
-
0:37
dr. petrylak on fda approval of nivolumab in bladder cancer
-
3:02
mediola: olaparib and durvalumab for germline brca-mutated metastatic breast cancer
-
4:16
durvalumab and oleclumab boost for sbrt plus chemo in er /her2- breast cancer
-
2:31
durvalumab plus tremelimumab or durvalumab monotherapy in metastatic urothelial carcinoma
-
9:17
i-spy 2: durvalumab in combination with olaparib and paclitaxel in high-risk her2 negative stage...
-
1:00
dr. black on combinations with durvalumab in bladder cancer
-
0:40
nadofaragene firadenovec shows durable responses in nmibc
-
1:05
dr. sonpavde on the role of durvalumab in platinum-refractory bladder cancer
-
4:21
durvalumab for treatment of advanced bladder cancer
-
2:55
highlights of durvalumab for advanced bladder cancer
-
6:04
durvalumab plus chemotherapy significantly improved os in advanced biliary tract cancer
-
2:36
exploring durvalumab with radiation therapy in patients with urothelial carcinoma
-
1:00
dr. joshi on durvalumab and radiation therapy in locally advanced urothelial cancer of the bladder
-
1:00
trial of durvalumab for bladder cancer
-
7:05
the fda approval of atezolizumab in bladder cancer
-
2:10
dr. langer on the benefit of durvalumab in stage iii nsclc